Tuesday, January 24, 2023

< + > The End Of Obesity

Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.

No comments:

Post a Comment

< + > Bonus Features, HIMSS Edition – March 11, 2026 – Epic AI news, Microsoft Dragon Copilot integrations, plus 22 other stories

Welcome to a special edition of Healthcare IT Today Bonus Features including interesting stories, product announcements, new hires, partner...